TUESDAY, June 8, 2021 (HealthDay News) — New research suggests that many people who’ve undergone an organ transplant do not get an immune response from COVID-19 vaccines that’s strong enough to ward off a “breakthrough” infection. In a new review of 14 such cases, these breakthrough COVID-19 infections occurred inContinue Reading

THURSDAY, June 3, 2021 (HealthDay News) — Parkinson’s disease patients can get symptom relief with deep brain stimulation (DBS) therapy that lasts over the long term, a new study shows. Over 15 years, patients who received DBS, which requires surgical implantation, had significant improvement in motor symptoms and less needContinue Reading

THURSDAY, May 27, 2021 (HealthDay News) — An experimental antibody therapy may help ease skin symptoms from the autoimmune disease lupus, a small preliminary trial suggests. Researchers found that a higher-dose version of the drug spurred a “clinically meaningful” symptom improvement for 87% of patients after one month. But theyContinue Reading

WEDNESDAY, May 26, 2021 (HealthDay News) — A widely used medicine for autoimmune diseases may lower people’s immune response to the Pfizer mRNA COVID-19 vaccine, a new study suggests. The drug, called methotrexate, is often given to patients with immune-mediated inflammatory conditions such as rheumatoid arthritis and psoriasis/psoriatic arthritis. “OurContinue Reading

THURSDAY, May 20, 2021 (HealthDay News) — A small but significant percentage of Americans take medications that can hamper their immune system and its response to COVID-19 vaccines, researchers say. Their analysis of data from more than 3 million adults under 65 with private insurance found that nearly 3% takeContinue Reading

TUESDAY, May 18, 2021 (HealthDay News) — New insight into a rare and dangerous disorder that can occur in kids with COVID-19 could improve treatment of the condition, researchers say. Many children infected with SARS-CoV-2 (the virus that causes COVID-19) go undiagnosed or have no symptoms, but about one inContinue Reading

WEDNESDAY, May 12, 2021 (HealthDay News) — Cora Oakley is a rough-and-tumble 4-year-old who loves gymnastics and outdoor activities, particularly if it involves bouncing on a trampoline. It’s hard to tell from looking at her that she was born without an immune system. Kids with this condition can acquire dangerous,Continue Reading

MONDAY, May 3, 2021 (HealthDay News) — Parkinson’s disease is widely seen as a movement disorder, but it can cause an array of symptoms, including hallucinations. Now a new study has shed light on what is happening in the brain during those disturbances. The study focused on Parkinson’s patients whoContinue Reading

FRIDAY, April 30, 2021 (HealthDay News) — COVID-19 infections may last longer in young people with weakened immune systems, and that extended period could lead to more mutations in SARS-CoV-2, according to the authors of a new case study. The study included two children and a young adult who hadContinue Reading

MONDAY, April 26, 2021 (HealthDay News) — A breakthrough psoriasis drug is better at treating the itchy and painful skin disease than medicines already on the market, according to results from two clinical trials. There was a “night and day difference” in the results from bimekizumab compared against two establishedContinue Reading

WEDNESDAY, April 21, 2021 (HealthDay News) — People who suffer a traumatic brain injury (TBI) have a significantly higher risk for stroke for years afterward, U.K. researchers say. Previous studies have linked brain injury with a long-term risk of neurological diseases including dementia, Parkinson’s and epilepsy, and it’s been suggestedContinue Reading

TUESDAY, April 20, 2021 (HealthDay News) — Men with certain sleep problems, like sleep walking, may be at a higher risk of developing Parkinson’s disease, a new study suggests. Among nearly 26,000 men, researchers found those who sleepwalked or had rapid eye movement sleep behavior disorder (RBD) had a fourContinue Reading

WEDNESDAY, April 7, 2021 (HealthDay News) — Two people in the Johnson & Johnson COVID-19 vaccine trial developed Guillain-Barré syndrome, but it’s highly doubtful the vaccine is to blame, according to a just-published case study. Although both people were in the same trial, one was given the vaccine and theContinue Reading